210 related articles for article (PubMed ID: 33314742)
21. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.
Ortega M; Bhatnagar H; Lin AP; Wang L; Aster JC; Sill H; Aguiar RC
Leukemia; 2015 Apr; 29(4):968-76. PubMed ID: 25311243
[TBL] [Abstract][Full Text] [Related]
22. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract][Full Text] [Related]
23. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
[TBL] [Abstract][Full Text] [Related]
24. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
[TBL] [Abstract][Full Text] [Related]
25. Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts.
Agnusdei V; Minuzzo S; Pinazza M; Gasparini A; Pezzè L; Amaro AA; Pasqualini L; Bianco PD; Tognon M; Frasson C; Palumbo P; Ciribilli Y; Pfeffer U; Carella M; Amadori A; Indraccolo S
Haematologica; 2020 May; 105(5):1317-1328. PubMed ID: 31467126
[TBL] [Abstract][Full Text] [Related]
26. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
27. NOTCH and PI3K-AKT pathways intertwined.
Gutierrez A; Look AT
Cancer Cell; 2007 Nov; 12(5):411-3. PubMed ID: 17996644
[TBL] [Abstract][Full Text] [Related]
28. CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
Chiang YJ; Liao WT; Ho KC; Wang SH; Chen YG; Ho CL; Huang SF; Shih LY; Yang-Yen HF; Yen JJ
Oncogene; 2019 Feb; 38(9):1432-1447. PubMed ID: 30266989
[TBL] [Abstract][Full Text] [Related]
29. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.
Palomero T; Ferrando A
Clin Lymphoma Myeloma; 2009; 9 Suppl 3(Suppl 3):S205-10. PubMed ID: 19778842
[TBL] [Abstract][Full Text] [Related]
31. Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1.
Tsai PY; Lee MS; Jadhav U; Naqvi I; Madha S; Adler A; Mistry M; Naumenko S; Lewis CA; Hitchcock DS; Roberts FR; DelNero P; Hank T; Honselmann KC; Morales Oyarvide V; Mino-Kenudson M; Clish CB; Shivdasani RA; Kalaany NY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653947
[TBL] [Abstract][Full Text] [Related]
32. miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia.
Saccomani V; Grassi A; Piovan E; Bongiovanni D; Di Martino L; Minuzzo S; Tosello V; Zanovello P
Cells; 2020 Jul; 9(7):. PubMed ID: 32708470
[TBL] [Abstract][Full Text] [Related]
33. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia.
Palomero T; Dominguez M; Ferrando AA
Cell Cycle; 2008 Apr; 7(8):965-70. PubMed ID: 18414037
[TBL] [Abstract][Full Text] [Related]
34. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
[TBL] [Abstract][Full Text] [Related]
35. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation.
Villar VH; Nguyen TL; Delcroix V; Terés S; Bouchecareilh M; Salin B; Bodineau C; Vacher P; Priault M; Soubeyran P; Durán RV
Nat Commun; 2017 Jan; 8():14124. PubMed ID: 28112156
[TBL] [Abstract][Full Text] [Related]
36. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
37. CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
[TBL] [Abstract][Full Text] [Related]
39. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
40. Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
van den Brandt J; Kwon SH; McPherson KG; Petrovic S; Zettl A; Müller-Hermelink HK; Reichardt HM
Eur J Immunol; 2006 Aug; 36(8):2223-34. PubMed ID: 16838279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
